Showing results (141-150 of 321) with videos related to
Sort By:
Pageof 33
Future Oncology (London, England)|June 4, 2016
Serum HER2 extracellular domain levels and HER2 circulating tumor cell status in patients with metastatic breast cancerGaetano Aurilio, Maria Teresa Sandri, Giancarlo Pruneri, et al.Cells|June 21, 2019
Development of Personalized Therapeutic Strategies by Targeting Actionable Vulnerabilities in Metastatic and Chemotherapy-Resistant Breast Cancer PDXsSimona Punzi, Marine Meliksetian, Laura Riva, et al.Molecular Oncology|December 10, 2013
Functional characterization of a novel FGFR1OP-RET rearrangement in hematopoietic malignanciesDaniela Bossi, Francesca Carlomagno, Isabella Pallavicini, et al.British Journal of Haematology|August 16, 2002
Microvessel density, a surrogate marker of angiogenesis, is significantly related to survival in multiple myeloma patientsGiancarlo Pruneri, Maurilio Ponzoni, Andrés J M Ferreri, et al.Cancer|October 19, 2022
Occurrence of breast-cancer-related lymphedema after reverse lymphatic mapping and selective axillary dissection versus standard surgical treatment of axilla: A two-arm randomized clinical trialMassimiliano Gennaro, Marco Maccauro, Luigi Mariani, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 12, 2020
Prognostic and predictive value of cell cycle progression (CCP) score in ductal carcinoma in situ of the breastMatteo Lazzeroni, Andrea DeCensi, Aliana Guerrieri-Gonzaga, et al.Acta Oncologica (Stockholm, Sweden)|January 19, 2013
Discordant hormone receptor and human epidermal growth factor receptor 2 status in bone metastases compared to primary breast cancerGaetano Aurilio, Lorenzo Monfardini, Stefania Rizzo, et al.Clinical Breast Cancer|April 25, 2015
Outcome of Immediate Breast Reconstruction in Patients With Nonendocrine-Responsive Breast Cancer: A Monoinstitutional Case-Control StudyGaetano Aurilio, Vincenzo Bagnardi, Franco Nolè, et al.Clinical Breast Cancer|October 27, 2012
Heterogeneity of triple-negative breast cancer: histologic subtyping to inform the outcomeEmilia Montagna, Patrick Maisonneuve, Nicole Rotmensz, et al.Cancer|July 9, 2026
Circulating tumor DNA in early breast cancer: Evidence, challenges, next stepsSerena Di Cosimo, Valentina Appierto, Carolina Reduzzi, et al.Pageof 33